Canada is signing deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to procure millions of doses of their experimental COVID-19 vaccines.
Procurement Minister Anita Anand announced the deals this morning in Toronto, which will see Canada get access to the vaccines if they prove to be both safe and effective.
Both companies began Phase 3 clinical trials of their vaccine candidates in the last week, large-scale tests to determine how well the vaccines work.
Earlier in July, both Pfizer and Moderna reported positive results from smaller trials. The Phase 3 trials will both test the vaccines on 30,000 people, and results are expected in the fall.
On a related note, the National Post reports that Canada’s first big push for a COVID-19 vaccine may be falling victim to sour relations with Beijing, as Chinese officials continue to hold up a shipment of the drug needed to carry out promised human trials in Canada. Read more, here.